Close

Dr Monica Arribas

Senior Trial manager and Research Fellow

United Kingdom

Tel.
+44 (0) 2072994684

Affiliations

Department of Medical Statistics
Faculty of Epidemiology and Population Health

Research

Research Area
Clinical trials
Global Health
Maternal health
Public health
Epidemiology
Randomised controlled trials
Disease and Health Conditions
Non-communicable diseases
Wounds and injuries
Country
Pakistan
Nigeria
Tanzania
Zambia
Region
World

Selected Publications

Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I'M WOMAN).
BRENNER, A; SHAKUR-STILL, H; Chaudhri, R; Muganyizi, P; Olayemi, O; ARRIBAS, M; Kayani, A; Javid, K; Bello, A; Roberts, I; I’M WOMAN Trial Collaborative Group,;
2023
Trials
Alternative routes for tranexamic acid treatment in obstetric bleeding (WOMAN-PharmacoTXA trial): a randomised trial and pharmacological study in caesarean section births.
SHAKUR-STILL, H; ROBERTS, I; Grassin-Delyle, S; Chaudhri, R; GEER, A; ARRIBAS, M; Lamy, E; MANSUKHANI, R; Lubeya, MK; Javaid, K; Kayani, A; Israr, N; Mazhar, SB; Urien, S; Bouazza, N; Foissac, F; Prowse, D; Carrington, L; Barrow, C; ONANDIA, JG; BALOGUN, E;
2023
BJOG : an international journal of obstetrics and gynaecology
Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: A systematic search and narrative review.
SHAKUR-STILL, H; Grassin-Delyle, S; Muhunthan, K; Ahmadzia, HK; Faraoni, D; ARRIBAS, M; ROBERTS, I;
2022
International journal of gynecology & obstetrics
Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers.
Grassin-Delyle, S; Semeraro, M; Lamy, E; Urien, S; Runge, I; Foissac, F; Bouazza, N; Treluyer, J-M; ARRIBAS, M; ROBERTS, I; SHAKUR-STILL, H;
2022
British Journal of Anaesthesia
Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid.
Grassin-Delyle, S; Lamy, E; Semeraro, M; Runge, I; Treluyer, J-M; MANSUKHANI, R; ARRIBAS, M; ROBERTS, I; SHAKUR-STILL, H;
2021
Frontiers in pharmacology
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
ROBERTS, I; SHAKUR-STILL, H; Afolabi, A; Akere, A; ARRIBAS, M; Austin, E; Bal, K; Bazeer, N; BEAUMONT, D; BRENNER, A; Carrington, L; Chaudhri, R; Coats, T; Gilmore, I; Halligan, K; Hussain, I; Jairath, V; Javaid, K; Kayani, A; Lisman, T; MANSUKHANI, R; MINERS, A; Mutti, M; Nadeem, MA; Pollok, R; ... WILLIAMS, J.
2021
Health technology assessment (Winchester, England)
Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
BRENNER, A; Belli, A; Chaudhri, R; Coats, T; Frimley, L; Jamaluddin, SF; Jooma, R; MANSUKHANI, R; Sandercock, P; SHAKUR-STILL, H; Shokunbi, T; ROBERTS, I; CRASH-3 trial collaborators,;
2020
CRITICAL CARE
See more information